1. Home
  2. QDEL vs VCEL Comparison

QDEL vs VCEL Comparison

Compare QDEL & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

HOLD

Current Price

$28.38

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$34.81

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QDEL
VCEL
Founded
1979
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
QDEL
VCEL
Price
$28.38
$34.81
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$40.00
$57.50
AVG Volume (30 Days)
1.0M
437.6K
Earning Date
02-11-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
$2,730,200,000.00
$258,716,999.00
Revenue This Year
N/A
$18.02
Revenue Next Year
$2.28
$18.52
P/E Ratio
N/A
$140.42
Revenue Growth
N/A
14.05
52 Week Low
$19.50
$29.24
52 Week High
$43.92
$58.77

Technical Indicators

Market Signals
Indicator
QDEL
VCEL
Relative Strength Index (RSI) 45.83 39.55
Support Level $27.75 $34.83
Resistance Level $30.50 $36.56
Average True Range (ATR) 1.50 1.61
MACD -0.03 -0.22
Stochastic Oscillator 56.50 10.66

Price Performance

Historical Comparison
QDEL
VCEL

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: